Publications by authors named "James Witter"

Claim this Profile
I
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.
Jennifer S Gewandter, Robert H Dworkin, Dennis C Turk, Eric G Devine, David Hewitt, James Witter

J Pain· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 6: creating national initiatives to support development and use-the PROMIS example.
Susan J Bartlett, James Witter, David Cella, Sara Ahmed

J Clin Epidemiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 8: patient-reported outcomes in electronic health records can inform clinical and policy decisions.
Sara Ahmed, Patrick Ware, William Gardner, James Witter, Clifton O Bingham

J Clin Epidemiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.
Shannon M Smith, Robert H Dworkin, Dennis C Turk, Ralf Baron, Michael Polydefkis, James Witter

J Pain· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.
Ann M Taylor, Kristine Phillips, Kushang V Patel, Dennis C Turk, Robert H Dworkin, James Witter

Pain· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: PROMIS a first look across diseases.
James P Witter

J Clin Epidemiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Promise of Patient-Reported Outcomes Measurement Information System-Turning Theory into Reality: A Uniform Approach to Patient-Reported Outcomes Across Rheumatic Diseases.
James P Witter

Rheum Dis Clin North Am· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Item response theory, computerized adaptive testing, and PROMIS: assessment of physical function.
James F Fries, James Witter, Matthias Rose, David Cella, Dinesh Khanna

J Rheumatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10.
Michael H Weisman, James P Witter, John D Reveille

Ann Rheum Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.
Stephen Bruehl, A Vania Apkarian, Jane C Ballantyne, Ann Berger, David Borsook, James Witter

J Pain· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey.
John D Reveille, James P Witter, Michael H Weisman

Arthritis Care Res (Hoboken)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, Laurie B Burke, John T Farrar, James Witter

Pain· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.
M Cary Reid, David A Bennett, Wen G Chen, Basil A Eldadah, John T Farrar, James Witter

Pain Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Domains selection for patient-reported outcomes: current activities and options for future methods.
Peter S Tugwell, Ingemar F Petersson, Maarten Boers, Laure Gossec, John R Kirwan, James P Witter

J Rheumatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, Ralf Baron, Nicholas Bellamy, James Witter

Pain· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).
Clifton O Bingham, Christoph Pohl, Thasia G Woodworth, Sarah E Hewlett, James E May, James P Witter

J Rheumatol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain and rheumatology: thinking outside the joint.
Daniel J Clauw, James Witter

Arthritis Rheum· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.
Dennis C Turk, Robert H Dworkin, Michael P McDermott, Nicholas Bellamy, Laurie B Burke, James Witter

Pain· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Kathleen W Wyrwich, Dorcas Beaton, Charles S Cleeland, James Witter

J Pain· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulating the development of mechanism-based, individualized pain therapies.
Janet Woodcock, James Witter, Raymond A Dionne

Nat Rev Drug Discov· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.
Thasia Woodworth, Daniel E Furst, Rieke Alten, Clifton O Bingham, David Yocum, James Witter

J Rheumatol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
Bernhard Hellmich, Oliver Flossmann, Wolfgang L Gross, Paul Bacon, Jan Willem Cohen-Tervaert, James Witter

Ann Rheum Dis· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Laurie B Burke, Richard Gershon, Margaret Rothman, James Witter

Pain· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibromyalgia syndrome.
Philip J Mease, Daniel J Clauw, Lesley M Arnold, Don L Goldenberg, James Witter

J Rheumatol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual responder analyses for pain: does one pain scale fit all?
Raymond A Dionne, Linda Bartoshuk, Jeffrey Mogil, James Witter

Trends Pharmacol Sci· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis